Bristol-Myers Squibb Company is in its Venus mahadasha (19 Apr 2024 to 19 Apr 2044), Venus antardasha (19 Apr 2024 to 19 Aug 2027) and Saturn pratyantar (9 Jun 2026 to 19 Dec 2026).
Next: pratyantar Mercury from 19 Dec 2026; antardasha Sun from 19 Aug 2027; mahadasha Sun from 19 Apr 2044.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Dhanu (Sagittarius) | 15°56′ | 12th | Purva Ashadha 1 |
| Moon | Mithuna (Gemini) | 25°35′ | 6th | Punarvasu 2 |
| Mars | Meena (Pisces) | 9°25′ | 3rd | Uttara Bhadrapada 2 |
| Mercury | Vrishchika (Scorpio) | 23°22′ | 11th | Jyeshtha 3 |
| Jupiter | Vrishchika (Scorpio) | 28°08′ | 11th | Jyeshtha 4 |
| Venus | Makara (Capricorn) | 17°11′ | 1st | Shravana 3 |
| Saturn (R) | Vrishabha (Taurus) | 6°02′ | 5th | Krittika 3 |
| Rahu | Makara (Capricorn) | 12°15′ | 1st | Shravana 1 |
| Ketu | Karka (Cancer) | 12°15′ | 7th | Pushya 3 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how BMY moved in each period against the S&P 500, transits, fundamentals and news.